Nautilus Biotechnology, Inc. (NAUT) vs OnKure Therapeutics, Inc. (OKUR)
Nautilus Biotechnology, Inc. and OnKure Therapeutics, Inc. are both Biotechnology companies. Nautilus Biotechnology, Inc. and OnKure Therapeutics, Inc. are of similar size ($126.1M and $118.7M). Across the 9 metrics below, OnKure Therapeutics, Inc. leads on 6 and Nautilus Biotechnology, Inc. on 3.
Valuation
Profitability
| Metric | NAUT | OKUR | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (36.21%) | (46.91%) | (57.72%) |
| Return on assets | (30.00%) | (44.24%) | (49.22%) |
| Return on invested capital | (83.32%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack